Stock ALXO ALX ONCOLOGY HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Strategies ALX Oncology Holdings Inc.

Equities

ALXO

US00166B1052

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-07 pm EDT 		5-day change 1st Jan Change
17.56 USD +11.28% Intraday chart for ALX Oncology Holdings Inc. +3.17% +17.93%
May. 07 ALX Oncology Appoints Allison Dillon as Chief Business Officer CI
Apr. 30 ALX Oncology Holdings Inc. Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer CI

MarketScreener Strategies

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALXO Stock
  4. News ALX Oncology Holdings Inc.
  5. MarketScreener Strategies
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW